ArticleCurrent microbiology2025
Myxococcus fulvus, as a Potential Isolate to be used as a Future Biocontrol Agent.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PredatoryFrontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Biological control has emerged as an alternative approach for mitigating plant diseases and minimizing the disproportionate use of agrochemicals and their hazardous impacts. Myxobacteria, a group of swarming soil bacteria, owing to their predatory mechanisms, are of particular interest such as their biocontrol potential. The present study investigates the antagonistic potential of myxobacteria isolated from various eco-geographical regions of India against phytopathogenic fungi, including Sclerotinia sp., Colletotrichum capsici, Aspergillus flavus, Fusarium solani, and Fusarium oxysporum. Myxococcus fulvus (ST/P/71) isolate exhibited significant broad-range antagonistic activity. ST/P/71 extract demonstrated antifungal activity against F. solani and inhibited biofilm formation by both F. solani and A. flavus. The ST/P/71 isolate was also observed to produce cell wall-degrading enzymes and the antifungal secondary metabolite myxothiazole A, suggesting their micro-predation capabilities against phytopathogens.
Indexed as
Identifiers
41369698What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.